Search results
Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?
Insider Monkey via Yahoo Singapore Finance· 4 weeks agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 2 months agoEstablishment Labs Holdings Inc. (NASDAQ:ESTA) Q1 2024 Earnings Call Transcript May 9, 2024...
Spectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 2 months agoSpectral AI, Inc. (NASDAQ:MDAI) Q1 2024 Earnings Call Transcript May 11, 2024 Spectral AI, Inc....
AbbVie Inc. (NYSE:ABBV) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 8 months agoAbbVie Inc. (NYSE:ABBV) Q3 2023 Earnings Call Transcript October 27, 2023 Operator: Good morning and...
San Francisco reaches $58 million opioid settlement with Teva, Allergan
Reuters via Yahoo News· 2 years agoTeva Pharmaceutical Industries and AbbVie's Allergan unit on Tuesday reached a $58 million...
AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News
Reuters via Yahoo News Singapore· 2 years agoThe deal would settle more than 3,000 lawsuits filed by state and local governments, but complete...
AbbVie Inc (ABBV) Faces Headwinds Amid Declining Revenues and Earnings
GuruFocus.com via Yahoo Singapore Finance· 5 months agoFull-Year Revenue: $54.318 billion, a decrease of 6.4% on a reported basis. Full-Year Diluted EPS:...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Singapore Finance· 4 months agoAbbVie Inc's robust immunology and oncology portfolio drives its competitive edge. Patent expirations and biosimilar competition present significant...
AbbVie Inc's Dividend Analysis
GuruFocus.com via Yahoo Singapore Finance· 3 months agoAbbVie Inc (NYSE:ABBV) recently announced a dividend of $1.55 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-12. As...
Q4 2023 Allogene Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Singapore Finance· 4 months agoParticipants Christine Cassiano; EVP, Chief Corporate Affairs and Brand Strategy Officer; Allogene Therapeutics Inc David Chang; President, Chief Executive Officer, Co-Founder, Director; Allogene ...
